Clinical Trial Update: Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating the safety, efficacy, and pharmacokinetics of DNB-001 in subjects with elevated intraocular pressure, including ocular hyperte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• DNB-001

Snippet

Sponsor: Danube Pharmaceuticals, Inc. | Conditions: Ocular Hypertension, Elevated IOP | Phase 1, Phase 2 | Status: COMPLETED